202 related articles for article (PubMed ID: 10835438)
21. Recombinant human erythropoietin in the treatment of acute ischemic stroke.
Ehrenreich H; Weissenborn K; Prange H; Schneider D; Weimar C; Wartenberg K; Schellinger PD; Bohn M; Becker H; Wegrzyn M; Jähnig P; Herrmann M; Knauth M; Bähr M; Heide W; Wagner A; Schwab S; Reichmann H; Schwendemann G; Dengler R; Kastrup A; Bartels C;
Stroke; 2009 Dec; 40(12):e647-56. PubMed ID: 19834012
[TBL] [Abstract][Full Text] [Related]
22. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
Lang W; Stadler CH; Poljakovic Z; Fleet D;
Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
[TBL] [Abstract][Full Text] [Related]
23. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
Soyka M; Friede M; Schnitker J
Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
[TBL] [Abstract][Full Text] [Related]
24. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
25. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
[TBL] [Abstract][Full Text] [Related]
26. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study.
van den Brink W; Sørensen P; Torup L; Mann K; Gual A;
J Psychopharmacol; 2014 Aug; 28(8):733-44. PubMed ID: 24671340
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety and efficacy of nalmefene in Japanese patients with alcohol dependence.
Higuchi S; Takahashi M; Murai Y; Tsuneyoshi K; Nakamura I; Meulien D; Miyata H
Psychiatry Clin Neurosci; 2020 Aug; 74(8):431-438. PubMed ID: 32359104
[TBL] [Abstract][Full Text] [Related]
29. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
Clark WM; Albers GW; Madden KP; Hamilton S
Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
[TBL] [Abstract][Full Text] [Related]
30. Nalmefene for elective reversal of procedural sedation in children.
Chumpa A; Kaplan RL; Burns MM; Shannon MW
Am J Emerg Med; 2001 Nov; 19(7):545-8. PubMed ID: 11698998
[TBL] [Abstract][Full Text] [Related]
31. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?
Bart G; Schluger JH; Borg L; Ho A; Bidlack JM; Kreek MJ
Neuropsychopharmacology; 2005 Dec; 30(12):2254-62. PubMed ID: 15988468
[TBL] [Abstract][Full Text] [Related]
32. The effects of nalmefene on emotion processing in alcohol use disorder - A randomized, controlled fMRI study.
Vollstädt-Klein S; Bumb JM; Otto A; Dinter C; Karl D; Koopmann A; Hermann D; Mann K; Kiefer F
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1442-1452. PubMed ID: 31740271
[TBL] [Abstract][Full Text] [Related]
33. Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results.
Lyden P; Shuaib A; Ng K; Levin K; Atkinson RP; Rajput A; Wechsler L; Ashwood T; Claesson L; Odergren T; Salazar-Grueso E;
Stroke; 2002 Jan; 33(1):122-8. PubMed ID: 11779900
[TBL] [Abstract][Full Text] [Related]
34. Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.
Barrio P; Ortega L; Guardia J; Roncero C; Yuguero L; Gual A
Clin Drug Investig; 2018 Feb; 38(2):147-155. PubMed ID: 29080208
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT).
Teal P; Davis S; Hacke W; Kaste M; Lyden PD; ; Fierus M;
Stroke; 2009 Nov; 40(11):3518-25. PubMed ID: 19745176
[TBL] [Abstract][Full Text] [Related]
36. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.
Sacco RL; DeRosa JT; Haley EC; Levin B; Ordronneau P; Phillips SJ; Rundek T; Snipes RG; Thompson JL;
JAMA; 2001 Apr; 285(13):1719-28. PubMed ID: 11277826
[TBL] [Abstract][Full Text] [Related]
37. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study.
Grant JE; Odlaug BL; Potenza MN; Hollander E; Kim SW
Br J Psychiatry; 2010 Oct; 197(4):330-1. PubMed ID: 20884959
[TBL] [Abstract][Full Text] [Related]
38. Nalmefene in alcohol-dependent patients with a high drinking risk: Randomized controlled trial.
Miyata H; Takahashi M; Murai Y; Tsuneyoshi K; Hayashi T; Meulien D; Sørensen P; Higuchi S
Psychiatry Clin Neurosci; 2019 Nov; 73(11):697-706. PubMed ID: 31298784
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
Walker BM; Koob GF
Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
[TBL] [Abstract][Full Text] [Related]
40. Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia.
Joshi GP; Duffy L; Chehade J; Wesevich J; Gajraj N; Johnson ER
Anesthesiology; 1999 Apr; 90(4):1007-11. PubMed ID: 10201671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
